Previous studies have found that HTRA1 has a clear proteolytic capability and a recognised effect in cartilage degeneration, skeletal disorders and cancers [35], and HTRA1 can bind to TGF-β1 and degrade and regulate the amount of TGF-β1 in vivo and in vitro [31,36]. This evidence concerns the gene HTRA1 and cancer.